Skip to content

Clinical trials

Phase 2 Adenoma, Islet Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenoma, Islet Cell Phase: Phase 2 Country / region: China Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20161
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status2
Completed1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Changhai Hospital1
Chinese Academy of Medical Sciences1
Fudan University1
Merck Sharp & Dohme LLC1
Peking Union Medical College Hospital1
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenoma, Islet Cell6
Carcinoid Tumor1
Neuroendocrine Tumors1
Paraganglioma1
Pheochromocytoma1
von Hippel-Lindau Disease1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.